valueequityanalysis.com

Independent, business-by-business valuations built from company filings — owner earnings, a ten-year outlook, and a bear / base / bull range. Search a ticker to see our estimate of what the business is worth.

Not investment advice. We are not registered investment advisers, and the people behind this site may hold or trade positions in companies analyzed here. Full disclosures.

Advanced Flower Capital Inc. (AFCG) stock intrinsic value fair value estimate & owner earnings analysis

Margin of safety$3.75 ComplexityHigh Updated
$3.00 $12.00
bear $3.00 base $9.00 bull $12.00 margin of safety $3.75 market price* $3.09
Business condition attached to the margin of safety One to two more quarters of results (beyond H1 2026) confirming net investment income has stabilized and no additional loans have joined the three already on nonaccrual/impaired status.
Advanced Flower Capital Inc. (formerly AFC Gamma, Inc.) is a specialty finance company that lends money to state-licensed cannabis operators, secured by real estate, equipment, cash flows and license value. It does not grow, process or sell cannabis itself; it is a lender to companies that do, in states where that business is legal. Because federal law still treats cannabis as illegal, these operators are largely shut out of ordinary bank financing, which is the opening AFC's lending fills - at high (double-digit) interest rates that compensate for that risk. In July 2024 the company distributed its non-cannabis commercial real estate loans to shareholders as a separate company (Sunrise Realty Trust), leaving AFC as a smaller, purely cannabis-focused lender. Effective January 1, 2026 it also converted from a REIT into a business development company (BDC), a different regulatory structure for lending vehicles that going forward requires it to distribute at least 90% of its taxable income. 2025 was a difficult year: three loans, together representing roughly 40% of the loan book by carrying value, stopped performing. The company recorded reserves and fair-value write-downs on them, producing a net loss of about $0.95 per share for the year, and the quarterly dividend was cut repeatedly, from roughly $0.48 in early 2024 to $0.05 by early 2026. Shareholders' equity per share fell from roughly $15-16 in 2022-2023 to about $8.25 today. Results turned positive again in the first half of 2026, consistent with the problem loans being worked through rather than the whole book deteriorating, but two quarters is not yet enough to call the business fully stabilized. Because this is a lending business, its value is built from what it earns on its loan book after funding costs and credit losses, rather than by separately subtracting debt - the borrowing is the raw material of the business and its cost is already counted as an expense. Bear case: the credit problems are not fully behind the company. Further borrowers in a legally fragile, cash-constrained industry struggle, credit losses continue at a similar pace to 2025, and because the company must pay out nearly all its income as a BDC, it retains little cushion to absorb more losses - shareholders' equity keeps drifting lower. On this path the shares are worth around $3. Base case: the three problem loans are resolved over the next few years without materially more loss than already reserved, the remaining loans (yielding low-to-mid teens interest) continue performing, and the company earns a modest return on its (now smaller) capital base, in line with the roughly 6% median return on equity it has produced through a full cycle of growth and losses since 2021. Book value holds roughly steady, since almost all earnings must be paid out. On this path the shares are worth around $9, close to today's book value per share. Bull case: the problem loans recover more value than currently assumed (the reserves and write-downs prove conservative), the remaining book continues earning mid-teens yields, and the company redeploys repaid capital into new loans at similar rates - a return toward the roughly 11-12% return on equity the company achieved in 2021-2022, before the credit losses. On this path the shares are worth around $12. A specific risk worth naming: because AFC must now distribute nearly all its taxable income under BDC/RIC rules, it has little retained-earnings buffer. Any new credit loss shows up almost immediately in book value per share, rather than being absorbed gradually - this is the main way the base case could prove too optimistic. Given the concentration in a handful of large loans (three loans represent a large share of the book) and the legal fragility of the underlying industry, a wide margin of safety is warranted. The margin-of-safety price is around $3.75 - not far above the bear-case value. It assumes another quarter or two of results confirming no new loans join the problem list, beyond the three already identified.
Fiscal yearOwner's earningsMethodology
2025 -$0.95 ▼
Financial business per 6.3: owner earnings = net income per diluted share. EPS diluted=-$0.95; diluted shares 22.28M; net loss ~$21.2M driven by CECL reserve and fair-value markdowns on three loans placed on nonaccrual status during 2025 (two loans held-for-investment, gross carrying value $88.8M written down to $49.4M net of CECL reserve; one loan held at fair value, principal $46.8M marked to $16.3M fair value) - combined nonaccrual exposure of ~$135.6M against a total loan portfolio of $332.6M fair value. Source: FY2025 Form 10-K, accession 0001628280-26-014392.
2024 $0.78 ▼
Financial business per 6.3: owner earnings = net income per diluted share. EPS diluted=$0.78; diluted shares 20.89M. Note: July 2024 spin-off of Sunrise Realty Trust (non-cannabis CRE lending book) distributed to shareholders, cutting stockholders' equity from ~$320M to ~$201M and concentrating the remaining book entirely in cannabis-sector lending; FY2024 reflects a partial year on the smaller post-spinoff base. Source: FY2024 Form 10-K, accession 0001822523-25-000003.
2023 $1.02 ▼
Financial business per 6.3: owner earnings = net income per diluted share. EPS diluted=$1.02; diluted shares 20.35M. Source: FY2023 Form 10-K, accession 0001822523-24-000014.
2022 $1.79 ▼
Financial business per 6.3: owner earnings = net income per diluted share. EPS diluted=$1.79; net income $35.9M; diluted shares 19.96M. Source: FY2022 Form 10-K, accession 0001822523-23-000006.
2021 $1.52 ▼
Financial business per 6.3: owner earnings = net income per diluted share. EPS diluted=$1.52; net income $21.0M; diluted shares 13.81M. Source: FY2021 Form 10-K, accession 0001140361-22-008768.
2020 $0.76 ▼
Financial business (specialty cannabis lender) per methodology 6.3: owner earnings = net income per diluted share (after interest expense); no net-debt subtraction since borrowings fund the loan book and interest is an operating cost. Partial period (inception 7/31/2020-12/31/2020). EPS diluted=$0.76. Source: FY2021 Form 10-K (comparative period), accession 0001140361-22-008768.

Owner's earnings per share by fiscal year, most recent first. Tap a row to see how that figure was calculated, including the source filing.

Sales geography
United States, nationwide - interest income earned on loans to state-licensed cannabis operators located across multiple U.S. states with legalized medical and/or adult-use cannabis programs (specific states not itemized in the filing); no international revenue.
Historical growth strategy

We don't have historical growth strategy information for this company yet.

Chart analysis
A chartist would describe a classic boom-bust-stabilize pattern. The stock rode the 2021 cannabis-sector enthusiasm to an early high not long after its 2021 IPO, then entered a prolonged, multi-year downtrend through 2022-2025 as the sector cooled and, more specifically to this name, as dividend cuts (from roughly $2.20/share annually in 2022 to about $0.20/share annualized by 2026) reduced its income support. The return to profitability in the first half of 2026 is the kind of fundamental inflection a chartist would look for a base or double-bottom to form around, though the stock has been driven more by credit-quality headlines than by technical levels.
Competitors

We don't have competitor information for this company yet.

Circle of competence

We don't have circle of competence information for this company yet.